arrow
S

Shiwu Zhang

the first affiliated hospital of nankai university
H指数:48
被引数:6,451

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating the efficacy and safety of pembrolizumab in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter, retrospective study analysis

评估pembrolizumab在复发或转移性头颈鳞状细胞癌中的疗效和安全性:一项多中心回顾性研究分析

2024-12-010
PRE
A phase I/II study of FG-M108 plus capecitabine and oxaliplatin (CAPOX) as first-line (1L) treatment for patients with CLDN18.2+/HER2-advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma

一项FG-M108联合卡培他滨和奥沙利铂(CAPOX)作为CLDN18.2+/HER2-晚期胃或胃食管结合部(G/GEJ)腺癌患者的一线(1L)治疗的I/II期研究

2024-09-013
PRE
Hydrogen sulfide improves endothelial barrier function by modulating the ubiquitination degradation of KLF4 through TRAF7 S-sulfhydration in diabetic aorta

硫化氢通过TRAF7 S-磺化调节糖尿病主动脉中KLF4的泛素化降解来改善内皮屏障功能

2024-04-013
PRE